Walleye Trading’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-200
Closed -$2.7K – 4705
2025
Q2
$2.7K Buy
+200
New +$2.19K ﹤0.01% 4118
2022
Q3
– Sell
-10,100
Closed -$277K – 5385
2022
Q2
$277K Buy
+10,100
New +$299K ﹤0.01% 3442
2022
Q1
– Sell
-100
Closed -$6K – 5757
2021
Q4
$6K Sell
100
-8,300
-99% -$629K ﹤0.01% 5185
2021
Q3
$719K Buy
+8,400
New +$527K ﹤0.01% 2567

Other funds holding OPRX

Walleye Trading's OPRX Position: Q3 2025 in Review

Walleye Trading sold out of OptimizeRx (OPRX) in Q3 2025, closing a stake of 9,887 shares — an estimated $133K sold.

Walleye Trading first reported a position in OPRX in Q2 2022 and held it in 2 quarters. The position peaked at $133K in Q2 2025. 125 funds tracked by Wall St. Rank hold OPRX as of Q3 2025.

  • Walleye Trading reported no remaining OptimizeRx position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 9,887 OptimizeRx shares in Q3 2025, an estimated $133K.
  • Walleye Trading first reported a position in OptimizeRx in Q2 2022 and held it in 2 quarters.
  • Walleye Trading's OptimizeRx position peaked at $133K in Q2 2025.
  • 125 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.